Financhill
Back

Arcutis Biotherapeutics Vs. SoftBank Group Industry Stock Comparison

Sell
39

ARQT
Arcutis Biotherapeutics

Last Price:
10.03
Seasonality Move:
-20.86%
Sell
45

SFTBY
SoftBank Group

Last Price:
29.86
Seasonality Move:
1.61%
Sell
39
Arcutis Biotherapeutics (ARQT) is a Sell

Is Arcutis Biotherapeutics a Buy, Sell or Hold?

  • The current Arcutis Biotherapeutics [ARQT] share price is $10.02. The Score for ARQT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • ARQT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
SoftBank Group (SFTBY) is a Sell

Is SoftBank Group a Buy, Sell or Hold?

  • The current SoftBank Group [SFTBY] share price is $29.86. The Score for SFTBY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • SFTBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARQT Stock Price Chart

What is Arcutis Biotherapeutics's stock price today?

  • The Arcutis Biotherapeutics share price today is $10.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARQT is experiencing slight selling pressure.

SFTBY Stock Price Chart

What is SoftBank Group's stock price today?

  • The SoftBank Group share price today is $29.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SFTBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

ARQT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 51.65 Buy
Chaikin Money Flow: -611479 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.61 - 10.69) Sell
Bollinger Bands (100): (8.58 - 10.38) Buy

SFTBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.27 Buy
Relative Strength Index (14 RSI): 53.06 Buy
Chaikin Money Flow: 400281 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.84 - 30.42) Buy
Bollinger Bands (100): (27.1 - 32.74) Sell

ARQT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.61 Buy
20-day SMA: 10.04 Sell
50-day SMA: 9.8 Buy
200-day SMA: 8.6 Buy
8-day EMA: 9.85 Buy
20-day EMA: 9.9 Buy
50-day EMA: 9.83 Buy
200-day EMA: 9.04 Buy

SFTBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.89 Sell
20-day SMA: 29.58 Buy
50-day SMA: 28.51 Buy
200-day SMA: 27.85 Buy
8-day EMA: 29.75 Buy
20-day EMA: 29.52 Buy
50-day EMA: 29.38 Buy
200-day EMA: 27.81 Buy

Arcutis Biotherapeutics Earnings Growth & ARQT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.45 per share, and an increase next year of $0.38 per share.

SoftBank Group Earnings Growth & SFTBY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Arcutis Biotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

SoftBank Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):